BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/22/2022 6:32:13 AM | Browse: 75 | Download: 145
 |
Received |
|
2022-03-28 10:51 |
|
Peer-Review Started |
|
2022-03-28 10:53 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-06-23 12:04 |
|
Revised |
|
2022-06-26 10:24 |
|
Second Decision |
|
2022-09-09 03:35 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-09-12 17:54 |
|
Articles in Press |
|
2022-09-12 17:54 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-09-07 13:29 |
|
Typeset the Manuscript |
|
2022-09-14 06:39 |
|
Publish the Manuscript Online |
|
2022-09-22 06:32 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Hyperprogression under treatment with immune-checkpoint inhibitors in patients with gastrointestinal cancer: A natural process of advanced tumor progression?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mo-Xuan Wang, Shu-Yue Gao, Fan Yang, Run-Jia Fan, Qin-Na Yang, Tian-Lan Zhang, Nian-Song Qian and Guang-Hai Dai |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Nian-Song Qian, PhD, Associate Professor, Department of Oncology, Senior Department of Respiratory and Critical Care Medicine, The Eighth Medical Center of Chinese PLA General Hospital, No.17 A Heishanhu Road, Haidian District, Beijing 100853, China. kyotomed@foxmail.com |
| Key Words |
Wang MX, Gao SY, Yang F, Fan RJ, Yang QN, Zhang TL, Qian NS, Dai GH. Hyperprogression under treatment with immune-checkpoint inhibitors in patients with gastrointestinal cancer: A natural process of advanced tumor progression? World J Clin Oncol 2022; In press |
| Core Tip |
Several literature reviews exist on the definition, incidence, predictors, potential biomarkers and prognosis for HPD. However, this is a mini review of two contending viewpoints: HPD as a new form of immunological response vs. natural advanced tumor progression. It also takes a look at cellular and molecular mechanisms of the pathways of tumor microenvironment and recent clinical trials exploring the risk factors and mechanisms of HPD in gastrointestinal cancer. |
| Publish Date |
2022-09-22 06:32 |
| Citation |
Wang MX, Gao SY, Yang F, Fan RJ, Yang QN, Zhang TL, Qian NS, Dai GH. Hyperprogression under treatment with immune-checkpoint inhibitors in patients with gastrointestinal cancer: A natural process of advanced tumor progression? World J Clin Oncol 2022; 13(9): 729-737 |
| URL |
https://www.wjgnet.com/2218-4333/full/v13/i9/729.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v13.i9.729 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
